6 Comments
User's avatar
Debbie Musielak's avatar

I’ve been on both. I think the compounded is often stronger, depending on the pharmacy, but I have lost on both. I actually prefer compounded since my insurance doesn’t cover the kiwikpens or vials. If Lilly would release the multidose vials and my insurance would cover them, I might like brand better since I could customize my doses easier.

John's avatar

Are people getting overdosed?

Jeanne Lightbody's avatar

They are rating cost. Compounded is more affordable.

Dr Efevretis's avatar

You're right not to read this as compounded outperforming branded, and the care-experience reframe is the useful one.

Worth adding the layer underneath it: the two groups were never comparable to begin with. Whoever ends up on compounded is self-selected, usually paying cash, and often inside exactly the high-touch telehealth setups you describe. So a satisfaction gap folds the molecule, the delivery model, and the type of patient into one number, and a satisfaction item was never an effectiveness measure anyway. The survey can't rank the drugs even in principle. It can only tell you who felt looked after.

Debbie Musielak's avatar

Congrats on the new sponsorship! That personalized care is going to make a big difference for so many!!